U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS
This repository is under review for potential modification in compliance with Administration directives.

Details

Stereochemistry ABSOLUTE
Molecular Formula C21H28O4
Molecular Weight 344.4446
Optical Activity UNSPECIFIED
Defined Stereocenters 7 / 7
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of DEPRODONE

SMILES

CC(=O)[C@@]1(O)CC[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@H]3[C@@H](O)C[C@]12C

InChI

InChIKey=KQZSMOGWYFPKCH-UJPCIWJBSA-N
InChI=1S/C21H28O4/c1-12(22)21(25)9-7-16-15-5-4-13-10-14(23)6-8-19(13,2)18(15)17(24)11-20(16,21)3/h6,8,10,15-18,24-25H,4-5,7,9,11H2,1-3H3/t15-,16-,17-,18+,19-,20-,21-/m0/s1

HIDE SMILES / InChI

Molecular Formula C21H28O4
Molecular Weight 344.4446
Charge 0
Count
Stereochemistry ABSOLUTE
Additional Stereochemistry No
Defined Stereocenters 7 / 7
E/Z Centers 0
Optical Activity UNSPECIFIED

Deprodone is a steroid that was approved in Japan for the treatment of inflammatory skin disorders. The drug is marketed under the name Eclar and contains 0.3% of the prodrug, deprodone propionate.

Approval Year

Conditions

Conditions

ConditionModalityTargetsHighest PhaseProduct
Primary
ECLAR

Approved Use

It is usually used to treat eczema, dermatitis, drug eruption, insect sting, prurigo, psoriasis, erythroderma, erythema, palmoplanter pustulosis, alopecia areata, etc.
Doses

Doses

DosePopulationAdverse events​
0.3 % 1 times / day multiple, topical
Recommended
Dose: 0.3 %, 1 times / day
Route: topical
Route: multiple
Dose: 0.3 %, 1 times / day
Sources:
unhealthy, ADULT
Health Status: unhealthy
Age Group: ADULT
Sex: M+F
Food Status: UNKNOWN
Sources:
Disc. AE: Ocular hypertension, Posterior capsule opacification...
Other AEs: Glaucoma...
AEs leading to
discontinuation/dose reduction:
Ocular hypertension
Posterior capsule opacification
Other AEs:
Glaucoma
Sources:
AEs

AEs

AESignificanceDosePopulation
Glaucoma
0.3 % 1 times / day multiple, topical
Recommended
Dose: 0.3 %, 1 times / day
Route: topical
Route: multiple
Dose: 0.3 %, 1 times / day
Sources:
unhealthy, ADULT
Health Status: unhealthy
Age Group: ADULT
Sex: M+F
Food Status: UNKNOWN
Sources:
Ocular hypertension Disc. AE
0.3 % 1 times / day multiple, topical
Recommended
Dose: 0.3 %, 1 times / day
Route: topical
Route: multiple
Dose: 0.3 %, 1 times / day
Sources:
unhealthy, ADULT
Health Status: unhealthy
Age Group: ADULT
Sex: M+F
Food Status: UNKNOWN
Sources:
Posterior capsule opacification Disc. AE
0.3 % 1 times / day multiple, topical
Recommended
Dose: 0.3 %, 1 times / day
Route: topical
Route: multiple
Dose: 0.3 %, 1 times / day
Sources:
unhealthy, ADULT
Health Status: unhealthy
Age Group: ADULT
Sex: M+F
Food Status: UNKNOWN
Sources:
Patents

Patents

Sample Use Guides

Deprodone (ointment or cream containing 0.3% deprodone propionate) is applied to the affected area, once to several times a day.
Route of Administration: Topical
In Vitro Use Guide
Unknown
Substance Class Chemical
Created
by admin
on Mon Mar 31 18:26:19 GMT 2025
Edited
by admin
on Mon Mar 31 18:26:19 GMT 2025
Record UNII
Z380L7N00P
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
DEPRODONE [MART.]
Preferred Name English
DEPRODONE
INN   MART.   WHO-DD  
INN  
Official Name English
Deprodone [WHO-DD]
Common Name English
deprodone [INN]
Common Name English
11.BETA.,17-DIHYDROXYPREGNA-1,4-DIENE-3,20-DIONE
Systematic Name English
PREDNISOLONE ACETATE IMPURITY D [EP IMPURITY]
Common Name English
11.BETA.,17-DIHYDROXYPREGNA-1,4-DIENE3,20-DIONE
Systematic Name English
PREGNA-1,4-DIENE-3,20-DIONE, 11,17-DIHYDROXY-, (11.BETA.)-
Systematic Name English
DESOLONE
Common Name English
Classification Tree Code System Code
NCI_THESAURUS C521
Created by admin on Mon Mar 31 18:26:19 GMT 2025 , Edited by admin on Mon Mar 31 18:26:19 GMT 2025
Code System Code Type Description
EVMPD
SUB06982MIG
Created by admin on Mon Mar 31 18:26:19 GMT 2025 , Edited by admin on Mon Mar 31 18:26:19 GMT 2025
PRIMARY
CAS
20423-99-8
Created by admin on Mon Mar 31 18:26:19 GMT 2025 , Edited by admin on Mon Mar 31 18:26:19 GMT 2025
PRIMARY
ChEMBL
CHEMBL2105540
Created by admin on Mon Mar 31 18:26:19 GMT 2025 , Edited by admin on Mon Mar 31 18:26:19 GMT 2025
PRIMARY
WIKIPEDIA
Deprodone
Created by admin on Mon Mar 31 18:26:19 GMT 2025 , Edited by admin on Mon Mar 31 18:26:19 GMT 2025
PRIMARY
ECHA (EC/EINECS)
243-809-6
Created by admin on Mon Mar 31 18:26:19 GMT 2025 , Edited by admin on Mon Mar 31 18:26:19 GMT 2025
PRIMARY
FDA UNII
Z380L7N00P
Created by admin on Mon Mar 31 18:26:19 GMT 2025 , Edited by admin on Mon Mar 31 18:26:19 GMT 2025
PRIMARY
EPA CompTox
DTXSID101043210
Created by admin on Mon Mar 31 18:26:19 GMT 2025 , Edited by admin on Mon Mar 31 18:26:19 GMT 2025
PRIMARY
PUBCHEM
10969997
Created by admin on Mon Mar 31 18:26:19 GMT 2025 , Edited by admin on Mon Mar 31 18:26:19 GMT 2025
PRIMARY
NCI_THESAURUS
C77412
Created by admin on Mon Mar 31 18:26:19 GMT 2025 , Edited by admin on Mon Mar 31 18:26:19 GMT 2025
PRIMARY
SMS_ID
100000083163
Created by admin on Mon Mar 31 18:26:19 GMT 2025 , Edited by admin on Mon Mar 31 18:26:19 GMT 2025
PRIMARY
INN
2428
Created by admin on Mon Mar 31 18:26:19 GMT 2025 , Edited by admin on Mon Mar 31 18:26:19 GMT 2025
PRIMARY
Related Record Type Details
PARENT -> IMPURITY
CHROMATOGRAPHIC PURITY (HPLC/UV)
EP
Related Record Type Details
ACTIVE MOIETY